News
03-11-2011, 07:20 AM
CytRx Corporation, a biopharmaceutical company specializing in oncology, today reported financial results for the 12 months ended December 31, 2010, and provided a business update.
More... (http://www.news-medical.net/news/20110311/CytRx-reports-2404M-net-income-for-2010-vs-2448M-net-loss-for-2009.aspx)
More... (http://www.news-medical.net/news/20110311/CytRx-reports-2404M-net-income-for-2010-vs-2448M-net-loss-for-2009.aspx)